Two spine devicemakers are expecting full-year revenue increases, according to unaudited financial results posted Jan. 12.
Carlsmed, which develops aprevo personalized spine implants expects full-year revenue of $50.5 million, an 86% increase compared to 2024. Fourth quarter revenue is expected to reach $15.2 million.
Alphatec expects full-year revenue of $764 million, a 25% increase year over year. The company is also eyeing fourth quarter revenue of $212.2 million to $213.2 million.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
